The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, putting them off cervical screening
Testing for HPV infection as the first step in analysing cervical screening samples is practical and more sensitive than the current programme
More than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.
Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.
A new cervical cancer test is big news this week. The science behind the headlines is exciting, but the test is a long way from being used in cervical screening.
Computer simulation suggests testing for HPV first could mean cervical screening can be stopped earlier
Cervical screening could be stopped at the age of 55 for some women if the HPV test is used first, according to a new computer simulation study.
A vaccine to prevent cervical cancer is safe and effective in reducing cell changes, a new review has confirmed.
Less than three quarters of eligible women are attending cervical cancer screening appointments in England, according to new figures.
New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK.
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine.